Huadong Chen

2.7k total citations
74 papers, 2.1k citations indexed

About

Huadong Chen is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Huadong Chen has authored 74 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 17 papers in Pharmacology and 12 papers in Oncology. Recurrent topics in Huadong Chen's work include Ginger and Zingiberaceae research (15 papers), PARP inhibition in cancer therapy (11 papers) and Phytochemical compounds biological activities (7 papers). Huadong Chen is often cited by papers focused on Ginger and Zingiberaceae research (15 papers), PARP inhibition in cancer therapy (11 papers) and Phytochemical compounds biological activities (7 papers). Huadong Chen collaborates with scholars based in China, United States and Hong Kong. Huadong Chen's co-authors include Shengmin Sang, Jian‐Min Yue, Shang‐Gao Liao, Sheng‐Ping Yang, Dominique N. Soroka, Yingdong Zhu, Xi Shao, Chi‐Tang Ho, Lishuang Lv and Renaud Warin and has published in prestigious journals such as Chemical Reviews, PLoS ONE and Cancer Research.

In The Last Decade

Huadong Chen

68 papers receiving 2.0k citations

Peers

Huadong Chen

PHARM

BIOCH

Yu Zhao China

Kuk Hyun Shin South Korea

Yeon Sil Lee South Korea

Kaeko Murota Japan

Iwao Toguchida Japan

Ciddi Veeresham India

Yijing Liao China

Xiaoqin Ding China

Jayaprakasam Bolleddula United States

Kohji Yamaki Japan

Yu Zhao China

Huadong Chen

1.0k ×1.0

264 ×0.5

PHARM

311 ×1.1

134 ×0.5

123 ×0.5

BIOCH

Citations per year, relative to Huadong Chen Huadong Chen (= 1×) peers Yu Zhao

Countries citing papers authored by Huadong Chen

Since Specialization

Citations

This map shows the geographic impact of Huadong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huadong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huadong Chen more than expected).

Fields of papers citing papers by Huadong Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huadong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huadong Chen. The network helps show where Huadong Chen may publish in the future.

Co-authorship network of co-authors of Huadong Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Huadong Chen. A scholar is included among the top collaborators of Huadong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huadong Chen. Huadong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Tonghan, et al.. (2025). Nanoshell-mediated color tuning of erbium-sensitized upconversion nanoparticles for advanced phototherapy above 1500 nm. Journal of Photochemistry and Photobiology A Chemistry. 463. 116285–116285. 3 indexed citations

Diolaiti, Morgan E., Huadong Chen, Junhao Lu, et al.. (2025). Structure-activity relationship studies on 2-thienylidene substituted 3-oxo-2,3-dihydrobenzofuran-7-carboxamides as poly (ADP-ribose) polymerase inhibitors. Bioorganic Chemistry. 165. 108941–108941.

Chen, Huadong, et al.. (2024). PARP7 Inhibitors and AHR Agonists Act Synergistically across a Wide Range of Cancer Models. Molecular Cancer Therapeutics. 24(1). 56–68. 6 indexed citations

Wang, Jing, Yi Zhang, Huadong Chen, et al.. (2024). Motor‐Cargo Structured Nanotractors for Augmented NIR Phototherapy via Gas‐Boosted Tumor Penetration and Respiration‐Impaired Mitochondrial Dysfunction. Advanced Healthcare Materials. 13(30). e2402063–e2402063. 7 indexed citations

Zou, Chuan, Changming Liu, Huadong Chen, et al.. (2024). Intervention strategies for management of comorbid depression among individuals with hypertension: a scoping review protocol. BMJ Open. 14(7). e085030–e085030.

Jiang, Hong, Huadong Chen, Chenglin Wu, et al.. (2023). Ex vivo tumor dissection followed by kidney autotransplantation in bilateral wilms tumor. Frontiers in Pediatrics. 11. 1120797–1120797. 2 indexed citations

Wang, Yuanqi, Xiao Xiang, Huadong Chen, et al.. (2023). Intratumoral erythroblastic islands restrain anti-tumor immunity in hepatoblastoma. Cell Reports Medicine. 4(5). 101044–101044. 13 indexed citations

Guo, Yuanli, Xinxin He, Junfeng Liu, et al.. (2023). ShallowHRD status acts as an effective prognostic predictor in ovarian cancer patients treated by poly (ADP-ribose) polymerase inhibitors (PARPis). Journal of Cancer Research and Clinical Oncology. 149(17). 15839–15844.

Chen, Huadong, Morgan E. Diolaiti, Patrick C. O’Leary, et al.. (2022). A Whole-Genome CRISPR Screen Identifies AHR Loss as a Mechanism of Resistance to a PARP7 Inhibitor. Molecular Cancer Therapeutics. 21(7). 1076–1089. 17 indexed citations

10.

O’Leary, Patrick C., Huadong Chen, Benjamin J. Polacco, et al.. (2022). Resistance to ATR Inhibitors Is Mediated by Loss of the Nonsense-Mediated Decay Factor UPF2. Cancer Research. 82(21). 3950–3961. 17 indexed citations

11.

Lin, Xiaofang, et al.. (2022). Multi-time scale transcriptomic analysis on the dynamic process of tamoxifen resistance development in breast cancer cell lines. Breast Cancer. 29(3). 458–467. 4 indexed citations

12.

Hayek, Saeed A., Salam A. Ibrahim, Huadong Chen, et al.. (2020). The Microbiota Is Essential for the Generation of Black Tea Theaflavins-Derived Metabolites. UNC Libraries.

13.

Tian, Changqing, Lin Chen, Huadong Chen, et al.. (2019). Inhibition of the BET family reduces its new target gene IDO1 expression and the production of l-kynurenine. Cell Death and Disease. 10(8). 557–557. 21 indexed citations

14.

Chen, Huadong, Shujian Huang, David Chiang, & Jiajun Chen. (2017). Improved Neural Machine Translation with a Syntax-Aware Encoder and Decoder. 1936–1945. 75 indexed citations

15.

Wang, Zhao, Ansha Zhao, Nan Huang, et al.. (2014). Cell adhesion on supported lipid bilayers functionalized with RGD peptides monitored by using a quartz crystal microbalance with dissipation. Colloids and Surfaces B Biointerfaces. 116. 459–464. 12 indexed citations

16.

Wang, Pei, et al.. (2014). Oat Avenanthramide-C (2c) Is Biotransformed by Mice and the Human Microbiota into Bioactive Metabolites. Journal of Nutrition. 145(2). 239–245. 65 indexed citations

17.

Chen, Huadong, Junsheng Fu, Hao Chen, et al.. (2014). Ginger Compound [6]-Shogaol and Its Cysteine-Conjugated Metabolite (M2) Activate Nrf2 in Colon Epithelial Cells in Vitro and in Vivo. Chemical Research in Toxicology. 27(9). 1575–1585. 61 indexed citations

18.

Zhu, Yingdong, Renaud Warin, Dominique N. Soroka, Huadong Chen, & Shengmin Sang. (2013). Metabolites of Ginger Component [6]-Shogaol Remain Bioactive in Cancer Cells and Have Low Toxicity in Normal Cells: Chemical Synthesis and Biological Evaluation. PLoS ONE. 8(1). e54677–e54677. 46 indexed citations

19.

Zhang, Jinwen, Mei Liao, Huadong Chen, & Yonghui Zhang. (2011). Structural elucidation of a new flavone fromSarcopyramis nepalensis. Journal of Asian Natural Products Research. 13(3). 256–259. 2 indexed citations

20.

Chen, Huadong, Jia Liu, Sheng Zhang, et al.. (2010). Mulavanins A–E: Limonoids from Munronia delavayi. Phytochemistry. 71(13). 1596–1601. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact